Rocket Pharmaceuticals, Inc.

RCKT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.41+9.65%

2026-08-03

Financials

Valuation Metrics

Rocket Pharmaceuticals, Inc.'s Market Cap is $372M. At end of 2025 it was $390M. Ranked #2908 of 3,112 in US market (top 93%), #1289 of 1,445 on NASDAQ (top 89%), #234 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 87%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$372M	US#2,908/3,112 Sec#234/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-209M	US—/3,112 Sec—/269
Total Assets	$285M	US#2,911/3,112 Sec#219/269
Net Assets	$238M	US#2,663/3,112 Sec#180/269
Value
P/B	1.56x	US#871/3,112 Sec#38/269
FCF Yield	-48.29%	US—/3,112 Sec—/269
Profitability
ROE	-87.96%	US#2,836/3,112 Sec#215/269
ROA	-73.36%	US#3,025/3,112 Sec#251/269
Financial Health
Debt Ratio	19.90%	US#225/3,112 Sec#79/269
Total Debt	$25M	US#2,666/3,112 Sec#172/269
FCF	$-180M	US#2,715/3,112 Sec#209/269
Cash	$50M	US#2,587/3,112 Sec#228/269
Current Ratio	6.12x	US#392/3,112 Sec#127/269
Performance
1Y Return	14.05%	US#1,726/3,112 Sec#177/269
1M Return	-11.20%	US#2,663/3,112 Sec#176/269
From 52W High	-37.43%	US#2,451/3,112 Sec#191/269
1Y MDD	-59.43%	US#2,701/3,112 Sec#210/269
Trading
Volume	3,150,133 shares	US#601/3,112 Sec#51/269
Trading Value	$10M	US#2,315/3,112 Sec#186/269
Per Share
EPS	$-2.01	US—/3,112 Sec—/269
BPS	$2.49	US#2,462/3,112 Sec#165/269